First Trust Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.5M | Sell |
|
|||||
2025
Q1 | $12.3M | Sell |
|
|||||
2024
Q4 | $20M | Buy |
|
|||||
2024
Q3 | $10.7M | Sell |
|
|||||
2024
Q2 | $26.8M | Buy |
|
|||||
2024
Q1 | $1.75M | Buy |
|
|||||
2023
Q4 | $971K | Sell |
|
|||||
2023
Q3 | $6.71M | Buy |
|
|||||
2023
Q2 | $556K | Buy |
|
|||||
2023
Q1 | $444K | Sell |
|
|||||
2022
Q4 | $1.56M | Sell |
|
|||||
2022
Q3 | $9.89M | Sell |
|
|||||
2022
Q2 | $25M | Buy |
|
|||||
2022
Q1 | $30M | Sell |
|
|||||
2021
Q4 | $38.1M | Buy |
|
|||||
2021
Q3 | $17.3M | Sell |
|
|||||
2021
Q2 | $187M | Buy |
|
|||||
2021
Q1 | $10.3M | Sell |
|
|||||
2020
Q4 | $15.5M | Buy |
|
|||||
2020
Q3 | $9.54M | Sell |
|
|||||
2020
Q2 | $105M | Buy |
|
|||||
2020
Q1 | $33.3M | Buy |
|
|||||
2019
Q4 | $39.2M | Buy |
|
|||||
2019
Q3 | $10.4M | Sell |
|
|||||
2019
Q2 | $29.9M | Sell |
|
|||||
2019
Q1 | $46.1M | Sell |
|
|||||
2018
Q4 | $38.6M | Buy |
|
|||||
2018
Q3 | $24.2M | Sell |
|
|||||
2018
Q2 | $53.1M | Buy |
|
|||||
2018
Q1 | $6.94M | Sell |
|
|||||
2017
Q4 | $5.91M | Sell |
|
|||||
2017
Q3 | $22.7M | Buy |
|
|||||
2017
Q2 | – | Sell |
|
|||||
2017
Q1 | $6.34M | Sell |
|
|||||
2016
Q4 | $25.5M | Sell |
|
|||||
2016
Q3 | $45.1M | Sell |
|
|||||
2016
Q2 | $39.9M | Sell |
|
|||||
2016
Q1 | $37.9M | Sell |
|
|||||
2015
Q4 | $79.3M | Buy |
|
|||||
2015
Q3 | $50.2M | Sell |
|
|||||
2015
Q2 | $86.9M | Sell |
|
|||||
2015
Q1 | $96.4M | Buy |
|
|||||
2014
Q4 | $66.9M | Sell |
|
|||||
2014
Q3 | $58.5M | Buy |
|
|||||
2014
Q2 | $13M | Buy |
|
|||||
2014
Q1 | $4.91M | Buy |
|